Genedx

GeneDx is a clinical genomic sequencing company founded in 1999, headquartered in Gaithersburg, Maryland. The company specializes in exome and whole genome sequencing for genetic diagnosis, serving patients, physicians, and healthcare systems in identifying genetic causes of disease. GeneDx was acquired by Invitae Corporation, a publicly traded genomic testing company, in 2021 for approximately $575 million. The acquisition expanded Invitae's portfolio of genetic testing capabilities and clinical data. GeneDx remains focused on providing accurate, clinically validated genetic testing to improve patient outcomes and support precision medicine approaches to diagnosis.